Bioniq, in partnership with Al Borg Diagnostics, is set to offer personalized supplements based on blood test data in key cities across Saudi Arabia. The strategic expansion plan aims to provide consumers with health solutions tailored to their specific needs. Bioniq’s CEO and founder, Vadim Fedotov, highlighted the company’s strategic objectives and plans in the Middle East and North Africa region, aiming to establish a strong presence and enhance access to personalized health solutions.
Through the partnership, consumers can utilize a 50-parameter blood test from Al Borg Diagnostics, followed by a personalized supplement formula created by Bioniq based on their health data. Fedotov emphasized the importance of quantifiable product efficacy, transparency, and customer satisfaction in their approach. The company aims to optimize health levels for customers across Saudi Arabia, leveraging strategic partnerships and comprehensive blood tests to offer advanced personalized health management.